Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers. [electronic resource]
Producer: 20171204Description: 749-57 p. digitalISSN:- 1754-8411
- Animals
- Breast Neoplasms -- genetics
- Chromosomes, Mammalian -- genetics
- Crizotinib
- DNA Copy Number Variations -- genetics
- Female
- Gene Expression Profiling
- Humans
- Mammary Neoplasms, Animal -- drug therapy
- Mice, Inbred BALB C
- Molecular Targeted Therapy
- Precision Medicine
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Tumor Suppressor Protein p53 -- deficiency
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.